Skip to main content

Keeping Cost Out of the Drug Approval Debate

Videos
Andrew Stainthorpe, PhD, PASLU, NICE, talks about why the FDA should not take drug cost into account when weighing the approval of expensive medications.
Last modified: August 30, 2021